This review describes experiments in cats and feline immune cells that support a role for inactivated FeLV and its p15E protein in reducing immune responses. The receptor for the part of the protein involved in this effect is still unknown, and the proposed communication pathways inside the cell remain unconfirmed. Findings in other retroviruses or species do not, on their own, show that the same occurs in FeLV-infected cats. The supplied text does not say how many animals or samples were studied in those feline experiments or provide figures for the size of the effects.
The review “Retrovirus-Induced Immunosuppression: Role of the Transmembrane Envelope Protein,” published in Viruses in 2026 (doi: 10.3390/v18070740), examines retrovirus-associated immunosuppression across multiple species. The supplied text describes FeLV-related experiments in cats and feline immune cells that support a role for inactivated FeLV and its transmembrane protein p15E in suppressing immune responses. Sample sizes and quantitative effect estimates are not reported for the feline experiments described.
Section 15 identifies the unknown receptor for the retroviral immunosuppressive domain as a major obstacle. The review does not establish a receptor identity for FeLV p15E. Available data suggest that the Ras-Raf-MEK-MAPK and PI3K-AKT-mTOR pathways are involved in immunosuppressive-domain signaling, but definitive evidence is lacking. Their involvement remains an open question and must not be presented as an established mechanism in FeLV-infected cats.
The authors also discuss conflicting findings on syncytin-1 immunosuppression and difficulties in interpreting domain mutations that can also impair viral infectivity. Findings involving other retroviruses or host species do not independently establish the same mechanisms or outcomes in FeLV-infected cats.
The experiments in cats and feline immune cells described in the review support a role for inactivated FeLV and p15E in suppressing immune responses. The supplied text provides neither sample sizes nor quantitative effect estimates for those experiments. Evidence from other retroviruses or species does not independently establish the same mechanisms or outcomes in FeLV-infected cats.
The identity of the receptor for the retroviral immunosuppressive domain remains unresolved; the review does not identify one for FeLV p15E. The involvement of Ras-Raf-MEK-MAPK and PI3K-AKT-mTOR in signaling by this domain also remains unconfirmed. Conflicting findings on syncytin-1 immunosuppression and difficulties in interpreting mutations that can also affect viral infectivity remain.
Section 15 states that available data suggest involvement of these pathways but definitive evidence is lacking. Their involvement must not be presented as an established mechanism in FeLV-infected cats.
Section 15 explicitly identifies the unknown receptor as a major obstacle. The review does not establish a receptor identity for FeLV p15E.
AVA